Routt, E. (2019). Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. SKIN The Journal of Cutaneous Medicine, 3(2), 150–151. https://doi.org/10.25251/skin.3.2.32